Plexxikon's Acquisition

Plexxikon was acquired by Daiichi Sankyo on March 02, 2011.

Plexxikon is a drug discovery company that utilizes a structural proteomics approach to discover pharmaceuticals. Using high-throughput X-ray crystallography, the company screens for chemical backbone…

Articles about Plexxikon's Acquisition: